Yuchai Enters Into Strategic Agreement in Vietnam
SINGAPORE, Feb. 20, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD) ("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary in China, Guangxi Yuchai Machinery...
Thailand BOI Approves Investments Worth A Total of US$5 Billion, Including TikTok's Data Hosting Project; Green Lights Revised Incentives for the Bioeconomy
BANGKOK, Jan. 29, 2025 /PRNewswire/ -- The Thailand Board of Investment (BOI) today approved investment privileges for projects worth a combined 170.5 billion baht (ca. US$5 Billion) in value, including a digital infrastructure project by leading...
Grant of Restricted Shares Under Big Tree Cloud Holdings Limited 2024 Equity Incentive Plan
SHENZHEN, China, Jan. 25, 2025 /PRNewswire/ -- Big Tree Cloud Holdings Limited ("Big Tree Cloud" or the "Company") (NASDAQ: DSY) (NASDAQ: DSYWW), a company devoted to the development, production, and sales of personal care products and other...
Clarity receives U.S. FDA Fast Track Designation for Cu-64 SAR-bisPSMA in biochemical recurrence of prostate cancer
SYDNEY, Jan. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and...
Lepu Biopharma has granted ArriVent Exclusive License for MRG007, a Potential Best-in-Class ADC for the treatment of Gastrointestinal Cancers
HONG KONG, Jan. 22, 2025 /PRNewswire/ -- Today, Lepu Biopharma Co., Ltd (Stock Code: 02157.HK) announced that it has entered into an exclusive licensing agreement with ArriVent BioPharma, Inc. for MRG007, a Potential Best-in-Class antibody- drug...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343 (Anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer
SAN FRANCISCO and SUZHOU, China, Jan. 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
The World's Most (and Least) Powerful Passports in 2025
LONDON, Jan. 8, 2025 /PRNewswire/ -- Singapore reclaims its crown as the most powerful passport in the world with visa-free access to 195 out of 227 destinations worldwide, leaving Japan as runner-up with a score of 193, according to the 2025 Henley...
U.S. FDA Granted Priority Review to Dizal's Sunvozertinib New Drug Application
If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins Sunvozertinib's NDA was submitted based on the multinational pivotal WU-KONG1 Part B...
CHINA NATURAL RESOURCES GRANTED SECOND 180-DAY PERIOD BY NASDAQ TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE RULE
HONG KONG, Jan. 6, 2025 /PRNewswire/ -- China Natural Resources Inc. (NASDAQ: CHNR) (the "Company") today announced that on January 3, 2025, the Company has been granted an additional 180-day period from Nasdaq's Listing Qualifications Department,...
Thailand BOI Approves 10.5 Billion Baht Investment by Foxsemicon Integrated Technology's Subsidiary to Make High-Precision Machinery Parts and Equipment for Semiconductor Sector
BANGKOK, Dec. 11, 2024 /PRNewswire/ -- The Thailand Board of Investment (BOI) today announced it has granted investment privileges to a 10.5 billion baht (ca. US$ 306 million) investment by UNIQUE Integrated Technology Co., Ltd., a subsidiary of...